The Leukemia & Lymphoma Society
1311 Mamaroneck Avenue
200 articles with The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society Launches IMPACT Research Grants to Help Underserved Patients Access Clinical Trials
Collaborations with Mayo Clinic, Vanderbilt University Medical Center and Weill Cornell Medicine will Increase Representation of Geographically, Ethnically and Economically Underserved Communities in Clinical Trials
Despite continued pandemic The Leukemia & Lymphoma Society remains unstoppable in its quest to end blood cancer
Nearly 1 in 3 blood cancer patients and survivors say they are unlikely to get a COVID-19 vaccine, or unsure about it, despite their heightened risk
BioIntelliSense Partners with Leukemia & Lymphoma Society to Incorporate the BioSticker™ Medical Device for Continuous Monitoring in Clinical Trials
LLS clinical trials will use the FDA-cleared BioSticker to evaluate correlation of vital signs and select symptoms to treatment [04-March-2021] DENVER , March 4, 2021 /PRNewswire/ -- BioIntelliSense, Inc. , a continuous health monitoring and clinical intelligence company, today announced the company has entered into a strategic partnership with The Leukemia & L
The Leukemia & Lymphoma Society Launches National Patient Registry to Answer Crucial COVID-19 Questions for Blood Cancer Patients
Collaboration with Ciitizen to Collect Data from Blood Cancer Patients Who Are More Vulnerable to Severe Illness and May Not Get Full Protection from COVID Vaccines
Burlington Stores & its Customers Raise Nearly $4 Million for The Leukemia & Lymphoma Society (LLS) in the Fight Against Blood Cancer
During an unparalleled year, Burlington's contribution supported LLS's mission and furthered the LLS Children's Initiative
Collaboration Driving Progress: LLS Forms Alliances with Leading Cancer Institutions and Foundations to Co-Fund nearly $17 million in New Research Grants
As the world confronts a viral pandemic not seen in the past 100 years, the reverberations are being felt across every sector, from healthcare to the economy, education, business and science, including the blood cancer community.
The Leukemia & Lymphoma Society and Rally Foundation for Childhood Cancer Research Announce Collaboration to Fight Pediatric Leukemia
The Leukemia & Lymphoma Society and Rally Foundation for Childhood Cancer Research announced that they are teaming up to fund a $400,000 research grant to fight pediatric acute myeloid leukemia, a disease that has seen limited advancement in therapies over the last several decades.
The Hairy Cell Leukemia Foundation and The Leukemia & Lymphoma Society Join Forces to Find New Therapies for Patients with this Rare Blood Cancer
The Hairy Cell Leukemia Foundation (HCLF) and The Leukemia & Lymphoma Society (LLS) announced today they are teaming up to support a research grants program of up to $10 million over five years, to build a more comprehensive understanding of hairy cell leukemia (HCL), develop better therapies and optimize outcom
Study in Nature Medicine Shows Superior Outcomes for Patients in The Leukemia & Lymphoma Society's Paradigm-Shifting Beat AML Clinical Trial
Patients participating in The Leukemia & Lymphoma Society's (LLS) groundbreaking precision medicine Beat AML Master Clinical Trial had superior outcomes compared to acute myeloid leukemia (AML) patients who opted for standard chemotherapy treatment, according to findings published today in the prestigious Nature Medicine
Canada's blood cancer community to unite at Light The Night, Take Back The Light virtual event amid pandemic
More than 50, 000 people from across the country are expected to take part in Light The Night, Take Back The Light – an annual flagship event hosted by The Leukemia & Lymphoma Society of Canada.
Loblaw Companies Limited step up in a time of crisis to help support Canadians affected by a blood cancer
The Leukemia & Lymphoma Society of Canada and Loblaw Companies Limited are pleased to announce this year's Give a Little, Help a Lot Light The Night campaign has raised $281,874 for Canadians affected by a blood cancer through in-store fundraising at its Superstore and Extra Food locations across the Western provinces and Ontario . Funds
33 Organizations Representing Millions of Patients Urge Policymakers to Adopt "Patient-First" Policy Agenda
A coalition of 33 organizations representing millions of people with pre-existing conditions launched an unprecedented effort by releasing their top priorities for the next Administration.
Amanda Yancey named Executive Director for The Leukemia & Lymphoma Society's Georgia - South Carolina Region
Amanda Yancey has been named the executive director of The Leukemia & Lymphoma Society's Georgia - South Carolina Region, as of September 1, 2020.
The Leukemia & Lymphoma Society Launches First Clinical Trial Specifically for Blood Cancer Patients with COVID-19
LLS's Innovative Beat AML Precision Medicine Clinical Trial Framework Will Expand to Test Treatment for Critically Ill Blood Cancer Patients with the Coronavirus
CURE® Speaking Out Video Series Supports Blood Cancer Awareness Month and World Lymphoma Awareness Day
Susan M. O’Brien, M.D., one of the nation’s foremost leukemia experts, discusses the future of frontline therapies and upcoming clinical trials associated with chronic lymphocytic leukemia.
PRA Health Sciences Joins The Leukemia & Lymphoma Society on Global Trial for Children with Acute Leukemia
LLS partners with PRA to help manage industry-first LLS PedAL master clinical trial to address the urgent need for new treatments for pediatric acute leukemia [03-September-2020] RYE BROOK, N.Y. and RALEIGH, N.C. , Sept. 3, 2020 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) and PRA Health Sciences (NASDAQ: PRAH) announced today a partnership to launch a
Global leader in fighting blood cancer, The Leukemia & Lymphoma Society, remains laser-focused on its mission amidst pandemic
Communities Nationwide Remain Laser-Focused on Helping Cancer Patients Who Can't Wait For Pandemic to Go Away
The Leukemia & Lymphoma Society Announces Winners of 2020 Man & Woman of the Year Fundraising Competition
The Leukemia & Lymphoma Society Today Announces a Collaboration with the National Cancer Institute and Children's Oncology Group on a Global Master Clinical Trial for Children with Acute Leukemia
New Study to Test Precision Medicine Treatments to Improve Outcomes for Children with Leukemia